Literature DB >> 16254340

Phosphorylation of the herpes simplex virus tegument protein VP22 has no effect on incorporation of VP22 into the virus but is involved in optimal expression and virion packaging of ICP0.

Corinne Potel1, Gillian Elliott.   

Abstract

Herpes simplex virus VP22 is a major tegument protein of unknown function. Very recently, we reported that the predominant effect of deleting the VP22 gene was on the expression, localization, and virion incorporation of ICP0. In addition, the Delta22 virus replicated poorly in epithelial MDBK cells. We have also previously shown that VP22 interacts with the tegument protein VP16 and the cellular microtubule network. While the majority of VP22 in infected cells is highly phosphorylated, the nonphosphorylated form of VP22 is the predominant species in the virion, suggesting a differential requirement for phosphorylation through virus replication. Hence, to study the significance of VP22 phosphorylation, we have now constructed two recombinant viruses expressing green fluorescent protein-VP22 (G22) in which the previously identified serine phosphorylation sites have been mutated either to alanine to abolish the phosphorylation status of VP22 (G22P-) or to glutamic acid to mimic permanent phosphorylation (G22P+). Localization studies indicated that the G22P- protein associated tightly with microtubules in some infected cells, suggesting that VP22 phosphorylation may control its interaction with the microtubule network. By contrast, VP22 phosphorylation had no effect on its ability to interact with VP16 and, importantly, had no effect on the relative packaging of VP22. Intriguingly, virion packaging of ICP0 was reduced in the G22P+ virus while ICP0 expression was reduced in the G22P- virus, suggesting that these two ICP0 defects, previously observed in the Delta22 virus, were attributable to different forms of VP22. Furthermore, the Delta22 virus replication defect in MDBK cells correlated with the expression of constitutively charged VP22 in the G22P+ virus. Taken together, these results suggest an important role for VP22 phosphorylation in its relationship with ICP0.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16254340      PMCID: PMC1280190          DOI: 10.1128/JVI.79.22.14057-14068.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Phosphorylation of MAP2c and MAP4 by MARK kinases leads to the destabilization of microtubules in cells.

Authors:  A Ebneth; G Drewes; E M Mandelkow; E Mandelkow
Journal:  Cell Motil Cytoskeleton       Date:  1999-11

2.  Microtubule binding of the drosophila DMAP-85 protein is regulated by phosphorylation in vitro.

Authors:  V Cambiazo; E Logarinho; H Pottstock; C E Sunkel
Journal:  FEBS Lett       Date:  2000-10-13       Impact factor: 4.124

Review 3.  Herpesvirus assembly and egress.

Authors:  Thomas C Mettenleiter
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

Review 4.  Virion-associated protein kinases.

Authors:  E K W Hui
Journal:  Cell Mol Life Sci       Date:  2002-06       Impact factor: 9.261

Review 5.  Protein kinases conserved in herpesviruses potentially share a function mimicking the cellular protein kinase cdc2.

Authors:  Yasushi Kawaguchi; Kentaro Kato
Journal:  Rev Med Virol       Date:  2003 Sep-Oct       Impact factor: 6.989

6.  Sequential localization of two herpes simplex virus tegument proteins to punctate nuclear dots adjacent to ICP0 domains.

Authors:  Ian Hutchinson; Alison Whiteley; Helena Browne; Gillian Elliott
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

7.  Deletion of the herpes simplex virus VP22-encoding gene (UL49) alters the expression, localization, and virion incorporation of ICP0.

Authors:  Gillian Elliott; Wali Hafezi; Alison Whiteley; Emmanuelle Bernard
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

8.  Tyrosine phosphorylation of bovine herpesvirus 1 tegument protein VP22 correlates with the incorporation of VP22 into virions.

Authors:  X Ren; J S Harms; G A Splitter
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

9.  Temporal regulation of herpes simplex virus type 2 VP22 expression and phosphorylation.

Authors:  B J Geiss; J E Tavis; L M Metzger; D A Leib; L A Morrison
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

10.  Physical interaction between envelope glycoproteins E and M of pseudorabies virus and the major tegument protein UL49.

Authors:  Walter Fuchs; Barbara G Klupp; Harald Granzow; Christoph Hengartner; Alexandra Brack; Alice Mundt; Lynn W Enquist; Thomas C Mettenleiter
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

View more
  15 in total

1.  Recruitment of herpes simplex virus type 1 immediate-early protein ICP0 to the virus particle.

Authors:  Kevin Maringer; Gillian Elliott
Journal:  J Virol       Date:  2010-02-17       Impact factor: 5.103

2.  Replication-competent herpes simplex virus 1 isolates selected from cells transfected with a bacterial artificial chromosome DNA lacking only the UL49 gene vary with respect to the defect in the UL41 gene encoding host shutoff RNase.

Authors:  Maria Teresa Sciortino; Brunella Taddeo; Maria Giuffrè-Cuculletto; Maria Antonietta Medici; Antonio Mastino; Bernard Roizman
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

3.  Virion incorporation of the herpes simplex virus type 1 tegument protein VP22 occurs via glycoprotein E-specific recruitment to the late secretory pathway.

Authors:  Julianna Stylianou; Kevin Maringer; Rachelle Cook; Emmanuelle Bernard; Gillian Elliott
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

4.  Elucidation of the block to herpes simplex virus egress in the absence of tegument protein UL16 reveals a novel interaction with VP22.

Authors:  Jason L Starkey; Jun Han; Pooja Chadha; Jacob A Marsh; John W Wills
Journal:  J Virol       Date:  2013-10-16       Impact factor: 5.103

5.  CK2 inhibitors increase the sensitivity of HSV-1 to interferon-β.

Authors:  Miles C Smith; Adam M Bayless; Erica T Goddard; David J Davido
Journal:  Antiviral Res       Date:  2011-06-22       Impact factor: 5.970

6.  Characterization of a UL49-null mutant: VP22 of herpes simplex virus type 1 facilitates viral spread in cultured cells and the mouse cornea.

Authors:  Carol Duffy; Jennifer H Lavail; Andrew N Tauscher; Elizabeth G Wills; John A Blaho; Joel D Baines
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

7.  A VP22-Null HSV-1 Is Impaired in Inhibiting CD1d-Mediated Antigen Presentation.

Authors:  Jianyun Liu; Richard M Gallo; Carol Duffy; Randy R Brutkiewicz
Journal:  Viral Immunol       Date:  2016-06-21       Impact factor: 2.257

8.  The varicella-zoster virus (VZV) ORF9 protein interacts with the IE62 major VZV transactivator.

Authors:  Cristian Cilloniz; Wallen Jackson; Charles Grose; Donna Czechowski; John Hay; William T Ruyechan
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

9.  Novel roles of cytoplasmic ICP0: proteasome-independent functions of the RING finger are required to block interferon-stimulated gene production but not to promote viral replication.

Authors:  Kathryne E Taylor; Marianne V Chew; Ali A Ashkar; Karen L Mossman
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

10.  VP22 of herpes simplex virus 1 promotes protein synthesis at late times in infection and accumulation of a subset of viral mRNAs at early times in infection.

Authors:  Carol Duffy; Ekaette F Mbong; Joel D Baines
Journal:  J Virol       Date:  2008-11-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.